Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication
 
HOUSE OF COMMONS   CHAMBRE DES COMMUNES
1st Session, 39th Parliament   1re Session, 39e législature

 
NOTICE OF MEETING   AVIS DE CONVOCATION
 
Standing Committee on Health   Comité permanent de la santé
 
AMENDED   MODIFIÉ
 
Meeting No. 47 Séance no 47
Monday, April 16, 2007 Le lundi 16 avril 2007
3:30 p.m. to 5:30 p.m. 15 h 30 à 17 h 30
Room 237-C, Centre Block   Pièce 237-C, édifice du Centre
(613-943-1496)   (613-943-1496)
 

 
 
Orders of the Day   Ordre du jour
 
 
Prescription Drugs (Common Drug Review) Médicaments sur ordonnance (Programme commun d'évaluation des médicaments)
 
Panel on Industry Perspectives Groupe de témoins sur le point de vue de l'industrie
 
Witnesses Témoins
 
Canada's Research-Based Pharmaceutical Companies (Rx & D) Compagnies de recherche pharmaceutique du Canada (Rx & D)
 
Russell Williams, President Russell Williams, président
 
Mark Ferdinand, Vice-President
Policy, Research, Regulatory and Scientific Affairs
 Mark Ferdinand, vice-président
Politiques, recherche, affaires réglementaires et scientifiques
 
Canadian Generic Pharmaceutical Association Association canadienne du médicament générique
 
Jim Keon, President Jim Keon, président
 
AMGEN Canada Inc. AMGEN Canada inc.
 
Daniel Billen, Vice-President and General Manager Daniel Billen, vice-président et directeur général
 
BIOTECanada BIOTECanada
 
Peter Brenders, President and Chief Executive Officer Peter Brenders, président et chef de la direction
 
Sean Thompson, Director, Corporate Development
YM Biosciences Inc.
 Sean Thompson, directeur, Développement des affaires
YM Biosciences inc.
 
 
La greffière du Comité
Carmen DePape ((613) 995-4108)
Clerk of the Committee
 
2007/04/12 10:57 a.m.   2007/04/12 10 h 57